Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category

Anti-TNFAIP3 antibody [EPR2663] (ab92324)

Price and availability

318 288 ₸

Availability

Order now and get it on Tuesday March 02, 2021

Anti-TNFAIP3 antibody [EPR2663] (ab92324)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
  • Rabbit monoclonal [EPR2663] to TNFAIP3
  • Suitable for: ICC/IF, WB, IHC-P, Flow Cyt
  • Knockout validated
  • Reacts with: Mouse, Human

You may also be interested in

anti-Golimumab ELISA Kit (Simponi®) (ab237662)
Product image
Anti-KIAA0408 antibody (ab247052)
Albendazole, Microtubule depolymerizing agent (ab141241)
Dinaline, Antineoplastic agent (ab144561)

Overview

  • Product name

    Anti-TNFAIP3 antibody [EPR2663]
    See all TNFAIP3 primary antibodies
  • Description

    Rabbit monoclonal [EPR2663] to TNFAIP3
  • Host species

    Rabbit
  • Specificity

    Mouse species is recommended based on WB results, we do not guarantee IHC-P for mouse.

  • Tested Applications & Species

    Application Species
    Flow Cyt
    Human
    ICC/IF
    Human
    IHC-P
    Human
    WB
    Mouse
    Human
    See all applications and species data
  • Immunogen

    Synthetic peptide within Human TNFAIP3 aa 500-600. The exact sequence is proprietary.
    (Peptide available as ab175807)

  • Positive control

    • WB: WEHI-3 treated with TNF (ab9642), Jurkat treated with TNF (ab9642) + TPA, Jurkat treated with 5ng/ml PMA for 48 hours and then treated with 2µg/ml PHA for 48 hours, HeLa, A549 and Daudi cell lysates. IHC-P: Human kidney tissue. ICC/IF: Daudi and HeLa cells. Flow Cyt: HepG2 and Daudi cells.
  • General notes

    This product is a recombinant monoclonal antibody, which offers several advantages including:

    • - High batch-to-batch consistency and reproducibility
    • - Improved sensitivity and specificity
    • - Long-term security of supply
    • - Animal-free production
    For more information see here.

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

    We are constantly working hard to ensure we provide our customers with best in class antibodies. As a result of this work we are pleased to now offer this antibody in purified format. We are in the process of updating our datasheets. The purified format is designated 'PUR' on our product labels. If you have any questions regarding this update, please contact our Scientific Support team.

Properties

  • Form

    Liquid
  • Storage instructions

    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C. Stable for 12 months at -20°C.
  • Storage buffer

    pH: 7.20
    Preservative: 0.01% Sodium azide
    Constituents: 59% PBS, 40% Glycerol, 0.05% BSA
  • Concentration information loading...
  • Purity

    Protein A purified
  • Clonality

    Monoclonal
  • Clone number

    EPR2663
  • Isotype

    IgG
  • Research areas

    • Immunology
    • Innate Immunity
    • Cytokines
    • TNF Superfamily
    • Signal Transduction
    • Growth Factors/Hormones
    • TNF
    • Cancer
    • Growth factors
    • TNF
    • Epigenetics and Nuclear Signaling
    • Ubiquitin & Ubiquitin Like Modifiers
    • Deubiquitination

Images

  • Western blot - Anti-TNFAIP3 antibody [EPR2663] (ab92324)
    Western blot - Anti-TNFAIP3 antibody [EPR2663] (ab92324)
    All lanes : Anti-TNFAIP3 antibody [EPR2663] (ab92324) at 1/1000 dilution

    Lane 1 : Wild-type A549 cell lysate
    Lane 2 : TNFAIP3 knockout A549 cell lysate
    Lane 3 : Wild-type HeLa cell lysate
    Lane 4 : TNFAIP3 knockout HeLa cell lysate

    Lysates/proteins at 20 µg per lane.

    Performed under reducing conditions.

    Predicted band size: 90 kDa
    Observed band size: 90 kDa



    Lanes 1- 4: Merged signal (red and green). Green - ab92324 observed at 90 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.

     ab92324 was shown to react with TNFAIP3 in wild-type A549 cells in western blot. Loss of signal was observed when knockout cell line ab266946 (knockout cell lysate ab257114) was used. Wild-type A549 and TNFAIP3 knockout A549 cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab92324 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TNFAIP3 antibody [EPR2663] (ab92324)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TNFAIP3 antibody [EPR2663] (ab92324)

    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human kidney tissue labelling TNFAIP3 with unpurified ab92324 at 1/50. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9. A prediluted HRP-polymer conjugated anti-rabbit IgG was used as the secondary antibody. Counterstained with Hematoxylin.

  • Immunocytochemistry/ Immunofluorescence - Anti-TNFAIP3 antibody [EPR2663] (ab92324)
    Immunocytochemistry/ Immunofluorescence - Anti-TNFAIP3 antibody [EPR2663] (ab92324)

    Immunocytochemistry/Immunofluorescence analysis of HeLa (Human epithelial cell line from cervix adenocarcinoma) labelling TNFAIP with purified ab92324 at 1/500. Cells were fixed with 4% PFA and permeabilized with 0.1% triton X-100. ab150077 Goat anti rabbit IgG (Alexa Fluor® 488) at 1/1000 was used as the secondary antibody. Nuclei were counterstained with DAPI. PBS was used instead of the primary antibody as the negative control.

  • Western blot - Anti-TNFAIP3 antibody [EPR2663] (ab92324)
    Western blot - Anti-TNFAIP3 antibody [EPR2663] (ab92324)
    All lanes : Anti-TNFAIP3 antibody [EPR2663] (ab92324) at 1/1000 dilution

    Lane 1 : Wild-type HeLa cell lysate
    Lane 2 : TNFAIP3 knockout HeLa cell lysate
    Lane 3 : Jurkat cell treated with 5ng/ml PMA for 48 hours and then treated with 2µg/ml PHA for 48 hours, whole cell lysate
    Lane 4 : Untreated Jurkat cell lysate

    Lysates/proteins at 20 µg per lane.

    Performed under reducing conditions.

    Predicted band size: 90 kDa
    Observed band size: 80 kDa
    why is the actual band size different from the predicted?



    Lanes 1-4: Merged signal (red and green). Green - ab92324 observed at 80 kDa. Red - loading control, ab8245 observed at 37 kDa.

    ab92324 Anti-TNFAIP3 antibody [EPR2663] was shown to specifically react with TNFAIP3 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265983 (knockout cell lysate ab257112) was used. Wild-type and TNFAIP3 knockout samples were subjected to SDS-PAGE. ab92324 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.

     

  • Western blot - Anti-TNFAIP3 antibody [EPR2663] (ab92324)
    Western blot - Anti-TNFAIP3 antibody [EPR2663] (ab92324)
    All lanes : Anti-TNFAIP3 antibody [EPR2663] (ab92324) at 1/1000 dilution

    Lane 1 : Wild-type A549 (Human lung carcinoma cell line) whole cell lysate
    Lane 2 : TNFAIP3 knockout A549 (Human lung carcinoma cell line) whole cell lysate
    Lane 3 : Jurkat (Human T cell leukemia cell line from peripheral blood) cell treated with 5ng/ml PMA for 48 hours and then treated with 2µg/ml PHA for 48 hours, whole cell lysate
    Lane 4 : Untreated Jurkat (Human T cell leukemia cell line from peripheral blood) whole cell lysate

    Lysates/proteins at 20 µg per lane.

    Secondary
    All lanes : Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) at 1/10000 dilution

    Predicted band size: 90 kDa
    Observed band size: 80 kDa why is the actual band size different from the predicted?



    Lanes 1-4: Merged signal (red and green). Green - ab92324 observed at 80 kDa. Red - loading control ab8245 observed at 36 kDa.

     ab92324 Anti-TNFAIP3 antibody [EPR2663] was shown to specifically react with TNFAIP3 in wild-type A549 cells. Loss of signal was observed when knockout cell line ab266945 (knockout cell lysate ab257113) was used. Wild-type and TNFAIP3 knockout samples were subjected to SDS-PAGE. ab92324 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

  • Western blot - Anti-TNFAIP3 antibody [EPR2663] (ab92324)
    Western blot - Anti-TNFAIP3 antibody [EPR2663] (ab92324)
    All lanes : Anti-TNFAIP3 antibody [EPR2663] (ab92324) at 1/5000 dilution

    Lane 1 : WEHI-3 (Mouse leukemia lymphoblast) whole cell lysate
    Lane 2 : WEHI-3 treated with 20 ng/ml TNF alpha (ab9642) for 6 h

    Lysates/proteins at 20 µg per lane.

    Secondary
    All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/20000 dilution

    Predicted band size: 90 kDa
    Observed band size: 80 kDa why is the actual band size different from the predicted?

  • Western blot - Anti-TNFAIP3 antibody [EPR2663] (ab92324)
    Western blot - Anti-TNFAIP3 antibody [EPR2663] (ab92324)
    Anti-TNFAIP3 antibody [EPR2663] (ab92324) at 1/2000 dilution (unpurified) + Jurkat cell lysate - treated with TNF (ab9642) and TPA at 10 µg

    Secondary
    Peroxidase-conjugated goat anti-rabbit IgG (H+L) at 1/1000 dilution

    Predicted band size: 90 kDa
    Observed band size: 80 kDa why is the actual band size different from the predicted?



    Blocking and dilution buffer: 5% NFDM/TBST.

  • Western blot - Anti-TNFAIP3 antibody [EPR2663] (ab92324)
    Western blot - Anti-TNFAIP3 antibody [EPR2663] (ab92324)
    Anti-TNFAIP3 antibody [EPR2663] (ab92324) at 1/3000 dilution (purified) + Jurkat cell lysate - treated with TNF (ab9642) and TPA at 10 µg

    Secondary
    Peroxidase-conjugated goat anti-rabbit IgG (H+L) at 1/1000 dilution

    Predicted band size: 90 kDa
    Observed band size: 80 kDa why is the actual band size different from the predicted?



    Blocking and dilution buffer: 5% NFDM/TBST.

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TNFAIP3 antibody [EPR2663] (ab92324)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TNFAIP3 antibody [EPR2663] (ab92324)

    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human kidney tissue labelling TNFAIP3 with purified ab92324 at 1/100. Heat mediated antigen retrieval was performed using Tris/EDTA buffer pH 9. A prediluted HRP-polymer conjugated anti-rabbit IgG was used as the secondary antibody. Counterstained with Hematoxylin.

  • Immunocytochemistry/ Immunofluorescence - Anti-TNFAIP3 antibody [EPR2663] (ab92324)
    Immunocytochemistry/ Immunofluorescence - Anti-TNFAIP3 antibody [EPR2663] (ab92324)

    Immunocytochemsitry/Immunofluorescence analysis of Daudi cells labelling TNFAIP3 (red) with unpurified ab92324 at 1/50. Cells were fixed with 4% paraformaldehyde. An Alexa Fluor® 555-conjugated goat anti-rabbit IgG (1/200) was used as the secondary antibody. Counterstained with DAPI (blue).

  • Immunocytochemistry/ Immunofluorescence - Anti-TNFAIP3 antibody [EPR2663] (ab92324)
    Immunocytochemistry/ Immunofluorescence - Anti-TNFAIP3 antibody [EPR2663] (ab92324)

    Immunocytochemsitry/Immunofluorescence analysis of Daudi cells labelling TNFAIP3 (red) with purified ab92324 at 1/100. Cells were fixed with 4% paraformaldehyde. An Alexa Fluor® 555-conjugated goat anti-rabbit IgG (1/200) was used as the secondary antibody. Counterstained with DAPI (blue).

  • Flow Cytometry - Anti-TNFAIP3 antibody [EPR2663] (ab92324)
    Flow Cytometry - Anti-TNFAIP3 antibody [EPR2663] (ab92324)

    Overlay histogram showing HepG2 cells stained with unpurified ab92324 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab92324, 1/50 dilution) for 30 min at 22ºC. The secondary antibody used was DyLight® 488 goat anti-rabbit IgG (H+L) (ab96899) at 1/500 dilution for 30 min at 22ºC. Isotype control antibody (black line) was rabbit IgG (monoclonal) (1µg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HepG2 cells fixed with 4% paraformaldehyde (10 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.

  • Flow Cytometry - Anti-TNFAIP3 antibody [EPR2663] (ab92324)
    Flow Cytometry - Anti-TNFAIP3 antibody [EPR2663] (ab92324)

    Flow cytometry analysis of Daudi cells labelling TNFAIP3 with unpurified ab92324 at 1/20 (red). Cells were fixed with 2% paraformaldehyde. A FITC-conjugated goat anti-rabbit IgG (1/150) was used as the secondary antibody. Green - Isotype control, rabbit monoclonal IgG.

  • Flow Cytometry - Anti-TNFAIP3 antibody [EPR2663] (ab92324)
    Flow Cytometry - Anti-TNFAIP3 antibody [EPR2663] (ab92324)

    Flow cytometry analysis of Daudi cells labelling TNFAIP3 with purified ab92324 at 1/30 (red). Cells were fixed with 2% paraformaldehyde. A FITC-conjugated goat anti-rabbit IgG (1/150) was used as the secondary antibody. Green - Isotype control, rabbit monoclonal IgG.

  • Western blot - Anti-TNFAIP3 antibody [EPR2663] (ab92324)
    Western blot - Anti-TNFAIP3 antibody [EPR2663] (ab92324)
    All lanes : Anti-TNFAIP3 antibody [EPR2663] (ab92324) at 1/1000 dilution (unpurified)

    Lane 1 : Jurkat cells treated with TNF (ab9642) and TPA
    Lane 2 : Daudi cell lysate

    Lysates/proteins at 10 µg per lane.

    Secondary
    All lanes : HRP labelled goat anti-rabbit IgG at 1/2000 dilution

    Predicted band size: 90 kDa

  • Anti-TNFAIP3 antibody [EPR2663] (ab92324)
    Anti-TNFAIP3 antibody [EPR2663] (ab92324)

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Anti-TNFAIP3 antibody [EPR2663] (ab92324)

  •  
  • Product image

    PerCP Anti-TNFAIP3 antibody [EPR2663] (ab220511)

    Applications: Flow Cyt

  •  
  • Product image

    Anti-TNFAIP3 antibody [59A426] (ab13597)

    Applications: Flow Cyt, IHC-P, WB

  •  
  • Product image

    Anti-TNFAIP3 antibody (ab193462)

    Applications: ICC/IF, IHC-P, WB

  •  
  • Product image

    Anti-TNFAIP3 antibody (ab74037)

    Applications: ICC/IF, WB

  •  
  • Product image

    Anti-TNFAIP3 antibody [EPR2663] - BSA and Azide free (ab227987)

    Applications: Flow Cyt, ICC/IF, IHC-P, WB

  •  
  • Product image

    Anti-TNFAIP3 antibody (ab111192)

    Applications: IHC-P

  •  
  • Product image

    Anti-TNFAIP3 antibody (ab93868)

    Applications: IP, WB

  •  
  • Product image

    Anti-TNFAIP3 antibody (ab155266)

    Applications: WB

  •  
  • Product image

    Alexa Fluor® 647 Anti-TNFAIP3 antibody [EPR2663] (ab197068)

    Applications: ICC/IF

Clear all

Recently viewed products

  •  
  • Product image

    Anti-Hsp90 beta antibody [K3701] (ab82584)

  •  
  • Product image

    Anti-Liver Arginase antibody [EPR6671(B)] (ab124917)

  •  
  • Product image

    Anti-PHF21B antibody [OTI3D1] (ab119249)

  •  
  • Product image

    Anti-CACNB1/CAB1 antibody (ab230019)

  •  
  • Product image

    Anti-TRAP220/MED1 (phospho T1457) antibody (ab182660)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.